Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
12/04/2008 | US20080299142 Compounds and methods for treatment and diagnosis of chlamydial infection |
12/04/2008 | US20080299139 Mammalian cytokines; related reagents and methods |
12/04/2008 | US20080299138 Toll-Like Receptor 3 Modulators and Uses Thereof |
12/04/2008 | US20080299135 Methods and compositions for nerve regeneration |
12/04/2008 | US20080299125 Genetic basis of treatment response in depression patients |
12/04/2008 | US20080299121 Multivalent recombinant antibodies for treating HRV infections |
12/04/2008 | US20080299119 Polypeptides homologous to vegf and bmp1 |
12/04/2008 | US20080299116 Vascular Endothelial Cell Growth Factor Antagonists and Uses Thereof |
12/04/2008 | US20080299113 Combined treatment with and composition of 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitor and anti-cancer agents |
12/04/2008 | US20080299109 Mechanism of astricyte-neuron signaling |
12/04/2008 | US20080299108 Peptides for Diagnostic and Therapeutic Methods for Celiac Sprue |
12/04/2008 | US20080299107 Combinations of human proteins to enhance viability of transplanted stem cells and progenitor cells |
12/04/2008 | US20080299106 Combinations of human proteins to enhance in vivo viability of stem cells and progenitor cells |
12/04/2008 | US20080299105 Inhibition of Feline Calicivirus |
12/04/2008 | US20080299104 Methods for detecting agents involved in neuronal apoptosis and compositions thereof |
12/04/2008 | US20080299103 Well Preserved Aqueous Organic Compositions |
12/04/2008 | US20080299102 Novel BACE proteins, nucleic acid molecules therefor, novel crystal structure of novel BACE proteins, and methods for making and using |
12/04/2008 | US20080299101 Cancer Treatment Resistance and Agents Modulating Such Resistance |
12/04/2008 | US20080299093 Premixed biological hydraulic cement paste composition and using the same |
12/04/2008 | US20080299089 Endogeneous repair factor production promoters |
12/04/2008 | US20080299088 Uses of Notch Receptors, Notch Ligands, and Notch Modulators in Methods Related to Metabolic Diseases |
12/04/2008 | US20080299083 Adenoviral vectors having a protein IX deletion |
12/04/2008 | US20080299081 Polynucleotides and Polypeptides of the IFNalpha-21 Gene |
12/04/2008 | US20080299080 Thiophene analogues for the treatment or prevention of flavivirus infections |
12/04/2008 | US20080299079 Absorption Enhancers for Drug Administration |
12/04/2008 | US20080299078 Tumor associated amino acids and uses therefor |
12/04/2008 | US20080299077 Isolation and growth of stem cells from hemangiomas |
12/04/2008 | US20080299076 Compunds and compositions that cause non-apoptotic cell death and uses thereof |
12/04/2008 | US20080299075 a mixture of viricides such as dimethyl(4,4'-biphenyldiylbis(1H-imidazole-4,2-diyl((1S)-2-methyl-1,1-propanediyl)imino((2S)-1-oxo-1,2-propanediyl)))biscarbamate, carriers and one or two additional antiviral drugs, used for the treatment of viral infections |
12/04/2008 | US20080299074 A-beta immunogenic peptide carrier conjugates and methods of producing same |
12/04/2008 | US20080299073 Method For Treatment Or Prophylaxis Of An Infection Using Either An Antibody Which Binds To IL-9 Or An Agent Which Stimulates Production Of Autoantibodies To Interleukin-9 |
12/04/2008 | US20080299072 Chemokine Antagonists |
12/04/2008 | US20080299071 Stable aqueous solutions of granulocyte macrophage colony-stimulating factor |
12/04/2008 | US20080299045 Composition for Prevention, Treatment, and Diagnosis of Chronic Obstructive Pulmonary Disease (Copd) |
12/04/2008 | US20080299040 Diagnosis and therapy of cancer and noncancerous diseases; complexes with radioactive material |
12/04/2008 | US20080299039 Aprotinin Polypeptides for Transporting a Compound Across the Blood-Brain Barrier |
12/04/2008 | DE102007025107A1 Arzneimittel zur Behandlung von Fertilitäts- und Schwangerschaftsstörungen und immunologisch-bedingten Erkrankungen und Transplantationen zur Anwendung in der Tiermedizin, insbesondere bei Pferden sowie Verfahren zur Herstellung Medicines used to treat fertility and pregnancy disorders and immunologically-related disorders and transplantation for use in veterinary medicine, particularly in horses and methods of making |
12/04/2008 | DE102007024852A1 Strongly enriching the amino acids and/or oligopeptides based on sweet whey powder, which is dissolved in water, comprises converting sugar to lactic acid and proteins to oligopeptides and amino acids using protease or lactic acid bacterium |
12/04/2008 | CA2692652A1 Hpv epitopes targeted by t cells infiltrating cervical malignancies for use in vaccines |
12/04/2008 | CA2689066A1 Reconstituted surfactants having improved properties |
12/04/2008 | CA2688587A1 Nucleic acid and amino acid sequences, and vaccine to control sea lice infestations in fish |
12/04/2008 | CA2688543A1 Vegf-d mutants and their use |
12/04/2008 | CA2688417A1 Calcium channel proteins and uses thereof |
12/04/2008 | CA2688344A1 Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues |
12/04/2008 | CA2688318A1 Whitening agent |
12/04/2008 | CA2688194A1 Antiviral drugs for treatment or prevention of dengue infection |
12/04/2008 | CA2688061A1 Multicistronic vectors and methods for their design |
12/04/2008 | CA2687990A1 Cross-linked collagen and uses thereof |
12/04/2008 | CA2687604A1 Methods for preparing factor x, activated factor x, inactivated factor x and inactivated factor xa, and pharmaceutical compositions comprising same |
12/04/2008 | CA2687377A1 Immunoglobulin fusion proteins |
12/04/2008 | CA2686803A1 Unacylated ghrelin as therapeutic agent in the treatment of metabolic disorders |
12/04/2008 | CA2686642A1 Process for providing a temperature - stable muscle relaxant on the basis of the neurotoxic component of botulinum toxin |
12/04/2008 | CA2686637A1 Process for providing a temperature - stable muscle relaxant on the basis of the neurotoxic component of botulinum toxin in solid form |
12/03/2008 | EP1998266A2 Method for identification of T-cell epitopes and use for preparing molecules with reduced immunogenicity |
12/03/2008 | EP1998177A2 Compositions and methods for diagnosing and treating colon cancers |
12/03/2008 | EP1997897A1 Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins |
12/03/2008 | EP1997895A1 Family of nucleic sequences and deduced protein sequences having human endogenous retroviral patterns, their flanking sequences and their applications |
12/03/2008 | EP1997893A1 Compositions containing an OX-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response |
12/03/2008 | EP1997891A1 Generation and selection of recombinant varied binding proteins |
12/03/2008 | EP1997890A1 Chinese hamster apoptosis-related genes |
12/03/2008 | EP1997829A1 Albumin fusion proteins |
12/03/2008 | EP1997828A2 Stabilized alpha helical peptides from BCL-2 and uses thereof |
12/03/2008 | EP1997827A1 Compounds analogous to growth hormone peptide secretagogues and preparations containing them |
12/03/2008 | EP1997826A2 Synthetic ligands for immunoglobulins and pharmaceutical compositions containing them |
12/03/2008 | EP1997823A1 Boronic ester and acid compounds, synthesis and uses |
12/03/2008 | EP1997514A1 High avidity polyvalent and polyspecific reagents |
12/03/2008 | EP1997513A1 Photodynamic therapy for treating conditions of the eye |
12/03/2008 | EP1997512A2 Methods for treating TWEAK-related conditions |
12/03/2008 | EP1997510A1 Non-neurotoxic plasminogen-activating factors for treating strokes |
12/03/2008 | EP1997509A1 Process for providing a temperature-stable muscle relaxant on the basis of the neurotoxic component of botulinum toxin |
12/03/2008 | EP1997508A2 S-adenosyl homocysteinase (SAHH) as a therapeutic agent for cancer |
12/03/2008 | EP1997507A2 Treatment of annulus fibrosis defects |
12/03/2008 | EP1997506A1 Use of ck2 inhibitor for the treatment and chemosensibilization of refractory tumors to anticancer drugs |
12/03/2008 | EP1997505A1 Erythropoietin solution preparation |
12/03/2008 | EP1997504A1 Novel antithrombotic agent |
12/03/2008 | EP1997503A2 Treatment of melanoma with alpha thymosin peptides |
12/03/2008 | EP1997502A1 Reconstituted surfactants having improved properties |
12/03/2008 | EP1997498A2 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport |
12/03/2008 | EP1997483A1 Rh-epo nasal formulations with low sialic acid concentration for the treatment of diseases of the central nervous system |
12/03/2008 | EP1996715A1 Bacterial antigens and uses thereof |
12/03/2008 | EP1996701A1 Cytotoxicity mediation of cells evidencing surface expression of trop-2 |
12/03/2008 | EP1996700A1 Cancerous disease modifying antibody 141205-05 |
12/03/2008 | EP1996615A2 Broad spectrum antiviral compositions |
12/03/2008 | EP1996612A1 Compositions for treatment of cancer |
12/03/2008 | EP1996609A2 Method of preparing glycopeptides |
12/03/2008 | EP1996608A1 Cyclopeptide with anti-cancer activity derived from collagen type iv |
12/03/2008 | EP1996606A1 Tropolone- and hydroxybenzene-substituted oligopeptides for depigmentation |
12/03/2008 | EP1996292A1 Use of peptides for the control of radiation injury |
12/03/2008 | EP1996233A2 Combinations comprising a histone deacetylase inhibiting agent and a nuclear hormone receptor ligand for treating cardiovascular conditions |
12/03/2008 | EP1996232A2 CANCER TREATMENT COMBINING LYMPHODEPLETING AGENT WITH CTLs AND CYTOKINES |
12/03/2008 | EP1996226A2 Methods, compositions and devices for maintaining chemical balance of chlorinated water |
12/03/2008 | EP1996225A1 Method and composition for protection against radiation |
12/03/2008 | EP1996224A1 Mixtures of amylin and insulin |
12/03/2008 | EP1996223A1 Acylated single chain insulin |
12/03/2008 | EP1996222A2 Endothelin and endothelin receptor agonists in the treatment of metabolic diseases |
12/03/2008 | EP1996221A2 Methods for reducing protein aggregation |
12/03/2008 | EP1996220A2 Unstructured recombinant polymers and uses thereof |
12/03/2008 | EP1996219A2 Treatment of ischemic disease using thrombopoietin |
12/03/2008 | EP1996218A2 Methods and compositions for the treatment of gastrointestinal disorders |
12/03/2008 | EP1996217A2 Novel antibiotic compositions |